HighTower Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
9,663
-21
| -0.2% | -$2.64K | ﹤0.01% | 1879 |
|
|
2025
Q1 | $1.07M | Sell |
9,684
-916
| -9% | -$101K | ﹤0.01% | 1916 |
|
|
2024
Q4 | $1.45M | Buy |
10,600
+1,013
| +11% | +$138K | ﹤0.01% | 1715 |
|
|
2024
Q3 | $1.1M | Sell |
9,587
-19,785
| -67% | -$2.28M | ﹤0.01% | 1875 |
|
|
2024
Q2 | $4.07M | Buy |
29,372
+13,434
| +84% | +$1.86M | 0.01% | 1092 |
|
|
2024
Q1 | $2.21M | Buy |
15,938
+556
| +4% | +$77.2K | ﹤0.01% | 1379 |
|
|
2023
Q4 | $2.03M | Buy |
15,382
+8,149
| +113% | +$1.07M | ﹤0.01% | 1415 |
|
|
2023
Q3 | $821K | Buy |
7,233
+625
| +9% | +$70.9K | ﹤0.01% | 1900 |
|
|
2023
Q2 | $626K | Sell |
6,608
-1,297
| -16% | -$123K | ﹤0.01% | 2041 |
|
|
2023
Q1 | $811K | Sell |
7,905
-381
| -5% | -$39.1K | ﹤0.01% | 1800 |
|
|
2022
Q4 | $997K | Buy |
8,286
+2,550
| +44% | +$307K | ﹤0.01% | 1666 |
|
|
2022
Q3 | $607K | Sell |
5,736
-57
| -1% | -$6.03K | ﹤0.01% | 1889 |
|
|
2022
Q2 | $566K | Buy |
5,793
+48
| +0.8% | +$4.69K | ﹤0.01% | 1955 |
|
|
2022
Q1 | $544K | Buy |
5,745
+1,883
| +49% | +$178K | ﹤0.01% | 2106 |
|
|
2021
Q4 | $332K | Sell |
3,862
-2,142
| -36% | -$184K | ﹤0.01% | 2401 |
|
|
2021
Q3 | $581K | Sell |
6,004
-26,344
| -81% | -$2.55M | ﹤0.01% | 1970 |
|
|
2021
Q2 | $3.15M | Buy |
32,348
+26,406
| +444% | +$2.57M | 0.01% | 983 |
|
|
2021
Q1 | $574K | Buy |
5,942
+224
| +4% | +$21.6K | ﹤0.01% | 1892 |
|
|
2020
Q4 | $551K | Sell |
5,718
-2,465
| -30% | -$238K | ﹤0.01% | 1577 |
|
|
2020
Q3 | $789K | Buy |
8,183
+3,631
| +80% | +$350K | ﹤0.01% | 1340 |
|
|
2020
Q2 | $555K | Sell |
4,552
-131
| -3% | -$16K | ﹤0.01% | 1398 |
|
|
2020
Q1 | $405K | Sell |
4,683
-267
| -5% | -$23.1K | ﹤0.01% | 1406 |
|
|
2019
Q4 | $532K | Buy |
4,950
+296
| +6% | +$31.8K | ﹤0.01% | 1419 |
|
|
2019
Q3 | $419K | Sell |
4,654
-34
| -0.7% | -$3.06K | ﹤0.01% | 1604 |
|
|
2019
Q2 | $396K | Buy |
4,688
+226
| +5% | +$19.1K | ﹤0.01% | 1633 |
|
|
2019
Q1 | $393K | Buy |
4,462
+356
| +9% | +$31.4K | ﹤0.01% | 1581 |
|
|
2018
Q4 | $293K | Sell |
4,106
-22
| -0.5% | -$1.57K | ﹤0.01% | 1613 |
|
|
2018
Q3 | $508K | Buy |
4,128
+22
| +0.5% | +$2.71K | ﹤0.01% | 1457 |
|
|
2018
Q2 | $404K | Sell |
4,106
-7
| -0.2% | -$689 | ﹤0.01% | 1538 |
|
|
2018
Q1 | $342K | Buy |
4,113
+1,307
| +47% | +$109K | ﹤0.01% | 1608 |
|
|
2017
Q4 | $218K | Buy |
+2,806
| New | +$218K | ﹤0.01% | 1858 |
|